[Antibiotics and quaternary ammonium compounds; research in vitro on the effects of combined achromycin and bradosol on Staphylococcus aureus and Escherichia coli].
D064751:Ammonium Compounds; D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D004926:Escherichia coli / Q000187:drug effects*; D066298:In Vitro Techniques; D008837:Micrococcus / Q000187:drug effects*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D013203:Staphylococcal Infections; D013211:Staphylococcus aureus; D013752:Tetracycline / Q000494:pharmacology*
D064751:Ammonium Compounds; D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D000644:Quaternary Ammonium Compounds; D013752:Tetracycline
ANTISEPTICS, QUATERNARY AMMONIUM/effects; ESCHERICHIA COLI/effect of drugs on; MICROCOCCUS PYOGENES/effect of drugs on; TETRACYCLINE/effects
Antibiotici e composti ammonio-quaternari; ricerche in vitro sugli effetti dell'associazione acromicinabradosol sullo stafilococcus aureus e sul B. Coli.